Add-on Acquisition • Life Science

Tosoh Bioscience Acquires Semba Biosciences

On October 4, 2021, Tosoh Bioscience acquired life science company Semba Biosciences

Acquisition Context

This is Tosoh Bioscience’s 1st transaction in the Life Science sector.
This is Tosoh Bioscience’s 1st transaction in the United States.
This is Tosoh Bioscience’s 1st transaction in Wisconsin.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	October 4, 2021
Target	Semba Biosciences
Sector	Life Science
Buyer(s)	Tosoh Bioscience
Deal Type	Add-on Acquisition

Target Company

Semba Biosciences

Madison, Wisconsin, United States

Semba Biosciences is a life science company that pioneered the development of multi-column chromatography (MCC) instrumentation and technology for downstream purification of biologics. Semba Biosciences was founded in 2005 and is based in Madison, Wisconsin.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Tosoh Bioscience

King of Prussia, Pennsylvania, United States

Category	Company
Sector	Medical Products

DESCRIPTION

Tosoh Bioscience is a provider of separation and purification products and technologies to the life sciences industry. Tosoh Bioscience offers pre-packed columns and bulk resins under the TSKgel, TOYOPEARL, and ToyoScreen brand names. Tosoh Bioscience is based in King of Prussia, Pennsylvania.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: Wisconsin	1 of 1
Country: United States	1 of 1
Year: 2021	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Wisconsin M&A - United States M&A - 2021 M&A